Jiménez Cruz Jorge, Diebolder Herbert, Dogan Askin, Mothes Anke, Rengsberger Mathias, Hartmann Michael, Meissner Winfried, Runnebaum Ingo B
Department of Gynaecology and Obstetrics, Jena University Hospital, Friedrich-Schiller-University Jena, Bachstraße 18, Jena 07743, Germany.
Pharmacy, Jena University Hospital, Friedrich-Schiller-University Jena, Erlanger Allee 101, Jena 07747, Germany.
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:11-6. doi: 10.1016/j.ejogrb.2014.05.001. Epub 2014 May 13.
To evaluate the effectiveness of intraoperatively applied local ropivacaine added to standard analgesic therapy in reducing postoperative pain intensity and opioid requirement under routine hospital conditions.
In this prospective controlled cohort study, 303 consecutive patients receiving a gynaecological laparoscopic intervention at the Jena University Hospital were included. The study cohort (n=168) received, in addition to standard pain management, a port-site (PS) infiltration with ropivacaine prior to incision and intraperitoneal (IP) instillation at the end of surgery. On the first postoperative day patients answered a validated questionnaire, and requirement of rescue analgesics was assessed.
Pain intensity was assessed on an 11-point numeric rating scale (NRS) from 0=no pain to 10=most severe pain. Reported pain intensity for movement-related pain was significantly lower (p=.001) in the study group compared with the control group (4.4 (SD 2.4) vs. 5.3 (SD 2.2) respectively). Minimal pain intensity after operation was also significantly lower in the study cohort (2.6 (SD 1.7) vs. 2.1 (SD 1.8), (p=.007)). Significantly fewer patients required rescue opioids for analgesia in the ropivacaine cohort (p=.001). The requested dose of rescue opioid (piritramide) in this cohort was also lower (p=.035) with 6.5mg (SD 4.9) vs. 8.7mg (SD 6.6), and demanded later (p=.001) with 4.3h after surgery vs. 3.1h. Patients in the study cohort experienced less nausea (p=.046). Higher satisfaction scores with pain management were reported in the ropivacaine group 12.7 (SD 2.5) vs. 11.6 (SD 2.8) (p<.001) (16-point NRS with 0=not at all, 15=completely satisfied).
Addition of pre-emptive port-site plus intraperitoneal ropivacaine to standard postoperative analgesic therapy reduced postoperative pain intensity and opioid consumption in gynaecological laparoscopy.
评估在常规医院条件下,术中应用局部罗哌卡因并联合标准镇痛疗法,在减轻术后疼痛强度及减少阿片类药物需求方面的有效性。
在这项前瞻性对照队列研究中,纳入了耶拿大学医院连续303例接受妇科腹腔镜手术的患者。研究队列(n = 168)除接受标准疼痛管理外,在切口前接受罗哌卡因切口部位浸润,手术结束时接受腹腔内滴注。术后第一天,患者回答一份经过验证的问卷,并评估急救镇痛药的需求。
采用11分数字评分量表(NRS)评估疼痛强度,0分为无疼痛,10分为最剧烈疼痛。研究组与对照组相比,与活动相关疼痛的报告疼痛强度显著更低(p = 0.001)(分别为4.4(标准差2.4)和5.3(标准差2.2))。研究队列术后最低疼痛强度也显著更低(2.6(标准差1.7)和2.1(标准差1.8),(p = 0.007))。罗哌卡因队列中需要急救阿片类药物镇痛的患者明显更少(p = 0.001)。该队列中急救阿片类药物(匹利卡明)的需求剂量也更低(p = 0.035),分别为6.5mg(标准差4.9)和8.7mg(标准差6.6),且需求时间更晚(p = 0.001),术后4.3小时与3.1小时。研究队列中的患者恶心症状更少(p = 0.046)。罗哌卡因组疼痛管理的满意度得分更高,为12.7(标准差2.5),而对照组为11.6(标准差2.8)(p < 0.001)(16分NRS,0分为完全不满意,15分为完全满意)。
在标准术后镇痛疗法中加入预防性切口部位加腹腔内罗哌卡因,可降低妇科腹腔镜手术的术后疼痛强度及阿片类药物消耗量。